INFLUENZA THERAPEUTICS MARKET ANALYSIS

Influenza Therapeutics Market, by Drug Type (Antivirals (Oseltamivir, Zanamivir, Peramivir, and Baloxavir Marboxil) and Vaccines (Quadrivalent Flu Vaccines and Trivalent Flu Vaccines)), by Virus Type, (Influenza Virus Type- A and Influenza Virus Type-B), by Age Group (Adult and Pediatrics), and by Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022-2028

To Be Published : Nov 2024
Code : CMI2443
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Key players operating in the global influenza therapeutic market include Daiichi Sankyo Company, GlaxoSmithKline plc, Natco Pharma, F. Hoffmann-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH (Novartis AG), Sun Pharmaceutical Industries Ltd., BiondVax Pharmaceuticals Ltd., Atriva Therapeutics Gmbh, Texas Medical Center, Life Science Austria (LISA), GE Healthcare Life Sciences, Sanofi Pasteur SA and Mylan, Inc.